It was proven that under dark conditions, the ZnONPs conjugated with methylthioadenosine phosphorylase (MTAP) anticancer drug to safely reach its intended site, and when exposed to ultraviolet A (UVA) radiation they were able to produce ROS, which significantly reduced the viability of cancer cells. The gene discussed is MTAP; the disease is cancer.